Mate Health has launched MateIQ, an AI tool designed to help men understand their semen analysis results from at-home testing. The tool uses a domain-specific large language model trained on clinical andrology data and reproductive health literature to translate lab reports into patient-friendly explanations.
MateIQ provides context across more than 20 semen parameters including morphology, motility, vitality, and DNA fragmentation. The tool is HIPAA-compliant.
“In a world where healthcare is increasingly delivered at home, men need tools that make reproductive testing clear and accessible,” said Ashmit Pyakurel, CTO and Co-Founder of Mate Health. “MateIQ provides that support by integrating at-home diagnostics with clear results, guidance, and education.”
Infertility affects 1 in 6 couples worldwide, with male factors contributing to nearly half of all cases. Many couples begin fertility treatment without evaluating the male partner, leading to delays and incomplete care pathways.
For OB/GYN and fertility practices, Mate Health offers an integrated program where practices provide patients with brochures featuring QR codes linking to the company’s website for test ordering. MateIQ then provides both patients and clinicians a conversational interface to review results and ask questions.
“Fertility has always been a shared experience, but too often the male side is overlooked,” said Paul Jurgensen, CEO and Co-Founder of Mate Health. “MateIQ helps close that gap by giving men an easy-to-use digital companion, providing clear, patient-friendly explanations of their results, shared insights to discuss with their partners, and guidance toward appropriate next steps with their providers.”
Early use by clinical partners has shown shorter timelines from referral to test completion and improved engagement among male patients, according to the company.
Mate Health is based in Chicago and offers at-home semen testing processed through a CLIA/CAP-certified high-complexity andrology laboratory.
